How is AI used today for drug development and aging research?

Every month, I sit down with a longevity pioneer or healthcare experts to dive deep into the science, investing and technological breakthroughs of aging

One of my guests was Alex Zhavoronkov, CEO of Insilico Medicine, a leader in the next-generation artificial intelligence and blockchain technologies for drug discovery, biomarker development, and aging research. At Insilico he pioneered the applications of generative adversarial networks and reinforcement learning techniques for generating the novel molecular structures with the desired properties. He set up the R&D centers in 6 countries including Korea, Russia, and Taiwan and launched multiple biomarker initiatives including Young.AI

In the webinar, he talked about the importance of aging biomarkers, and how AI can radically transform aging research and support extending lifespan

Are you interested in watching the full webinar, and participating in upcoming ones? Sign up to become a Longevity Ambassador! https://sergeyyoung.com/ama-list

I also wrote my first book on Longevity, "The Science and Technology of Growing Young": https://sergeyyoung.com/book

Видео How is AI used today for drug development and aging research? канала Sergey Young